Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03758755 · ClinicalTrials.gov registry record · NA
Blood Flow Restriction Following ACL Reconstruction
A NA study, sponsored by Inova Health Care Services.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT03758755 is a NA study that has completed, run by Inova Health Care Services. The registered enrollment target is 49 participants.
The verdict
NCT03758755, a NA study, has completed, sponsored by Inova Health Care Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
The main objective is to determine the impact of Blood Flow Restriction (BFR) therapy, in comparison to a standard rehabilitation protocol, on preventing atrophy, improving quadriceps strength and improving functional outcomes of patients recovering from ACL reconstruction. The investigators hypothesize that patients undergoing BFR therapy after ACL reconstruction surgery will have better functional outcomes than those undergoing normal rehabilitation without BFR therapy.
Interventions
- DEVICE Blood Flow Restriction Therapy
- OTHER ACL Reconstruction rehabilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2022-10-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03758755
The ClinicalTrials.gov registry entry for NCT03758755 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood Flow Restriction Therapy is the first listed.
NCT03758755 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03758755 about?
NCT03758755 is a clinical study titled "Blood Flow Restriction Following ACL Reconstruction". The main objective is to determine the impact of Blood Flow Restriction (BFR) therapy, in comparison to a standard rehabilitation protocol, on preventing atrophy, improving quadriceps strength and improving functional outcomes of patients recovering from ACL reconstruction. The investigators hypothe...
What is the current status of trial NCT03758755?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2018-11-01. Estimated completion is 2022-10-26.
What interventions are being tested in trial NCT03758755?
The interventions under investigation include: Blood Flow Restriction Therapy (DEVICE), ACL Reconstruction rehabilitation (OTHER).
Who is sponsoring clinical trial NCT03758755?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.